Smart Medical Devices Market Size Report | Growth, Statistics and Forecasts 2030

Coverage: Smart Medical Devices Market covers analysis By Product Type (Diagnostic Devices, Therapeutic Devices, Injury Prevention & Rehabilitation Devices, and Others), Test Type (Portable and Wearable), End User (Hospitals & Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

  • Report Code : TIPRE00031453
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

The smart medical device market size is expected to grow from US$ 34,800.23 million in 2022 to US$ 1,14,900.88 million by 2030; it is estimated to register a CAGR of 15.7% from 2022 to 2030.

Analyst’s ViewPoint



The smart medical device market analysis explains market drivers, such as the rising prevalence of chronic diseases, as a standalone factor responsible for influential market growth. Further, technological advancement is expected to introduce new trends in the market during 2022-2030. Based on product type, the market is segmented as diagnostic devices, therapeutic devices, injury prevention & rehabilitation devices, and others. The diagnostic devices segment accounted for a larger share in 2022. Based on test type, the wearable segment dominated the market by accounting for the maximum share. By end-user segment, the hospitals & clinics segment is likely to account for a considerable share of the smart medical device market during the forecast period.

Smart medical devices integrate advanced technology and computational capabilities to enhance medical diagnosis, treatment, and monitoring. These smart medical devices utilize sensors, AI, machine learning, and connectivity features to collect, analyze, and interpret patient's health data. The data collected helps to facilitate personalized and proactive care, improve healthcare outcomes, and empower both patients and medical professionals with actionable insights and decision support for physicians. ECG Monitors, spirometers, insulin pumps, and inhalers are examples of such smart medical devices. Further, smart medical devices help to connect patients to doctors, transmitting critical medical data in real-time from hospital beds and private homes, as well as mobile equipment used at emergency sites and transport vehicles. Such collected patient data will enable the healthcare providers that help the physicians and patients to monitor health changes continuously, ultimately providing real-time data and providing patients the highest level of care.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Smart Medical Devices Market: Strategic Insights

Smart Medical Devices Market

  • CAGR (2023 - 2031)
    15.70%
  • Market Size 2023
    US$ 40.26 Billion
  • Market Size 2031
    US$ 129.30 Billion

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Key Players

  • Abbott Laboratories
  • Apple, Inc.
  • Dexcom, Inc.
  • Fitbit, Inc.
  • F. Hoffman-La-Roche Ltd.
  • Johnson & Johnson
  • Medtronic
  • NeuroMetrix, Inc.
  • Zephyr

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Product Type
  • Diagnostic Devices
  • Therapeutic Devices
  • Injury Prevention & Rehabilitation Devices
  • Others
Test Type
  • Portable and Wearable
End User
  • Hospitals & Clinics
  • Homecare Settings
  • Others
Geography
  • North America
  • Europe
  • Asia Pacific
  • South & Central America
  • Middle East & Africa
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights



Rising Prevalence of Chronic Diseases



According to the National Health Council (NHC) report, chronic disease affects approx. 133 million Americans, representing more than 40% of the total population in the US alone. Additionally, about half of all adults have a chronic condition, with approx. 8% of children are affected at the age of 5 to 17, reporting suffering from at least one chronic disease or disability. The Centers for Disease Control and Prevention (CDC) report in the US alone, chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability, accounting for US$4.1 trillion in healthcare costs annually. The most impacting factors of the US population suffering from chronic diseases include high exposure to tobacco and smoking, poor nutrition, less physical activity, and excessive alcohol use. Therefore, there is a high adoption of smart medical devices globally that interacts with the physical systems of the population suffering from health ailments, offering significant safety implications. For example, heart disease is the leading cause of death globally. Therefore, an artificial heart remains only a temporary solution until a donor is found for carrying implant cardiac surgery. However, the adoption of smart devices proves beneficial for the early discovery of abnormalities to avoid long-term damage or predict the risk of cardiac arrest.

Further, several companies are launching innovative smart medical device products. For example, in April 2022, Abbott announced a partnership with CamDiab and Ypsomed to develop and commercialize an integrated automated insulin delivery (AID) system. The new AID system will lessen the burden of round-the-clock diabetes management for people who have diabetes. Also, the new AID system will be designed to connect with "Abbott's FreeStyle Libre 3 Sensor" to "CamDiab's CamAPS FX mobile app" and, finally, Ypsomed's "YpsoPump" to create an innovative and automated process to deliver insulin based on real-time glucose data.

Therefore, the high adoption of smart medical devices for managing chronic diseases among the population for early detection of disease is a standalone factor responsible for the influential growth of the market in the forecast period 2020-2030.

Future Trend



Technological Advancement



Technological progress is advancing scientific knowledge, reducing costs, and presenting the healthcare sector with innovative medical devices and procedures capable of diagnosing, monitoring, and treating medical conditions. Also, the Food and Drug Administration's (FDA) approval of new innovative smart medical device products further enhances the adoption among the population globally to improve patient care and reduce operational costs. The "Vios Chest Sensor" is a wireless device and is one such example of an FDA-approved medical device. The "Vios Chest Sensor" enables continuous monitoring of a patient's vital signs data, and its small size and wireless connectivity offer a 7-lead ECG, heart rate, respiratory rate, SpO2, pulse rate, posture, and activity. The "Vios Central Station Monitor and Software solution enables monitoring of vital signs of multiple patients simultaneously and intuitively navigates between screens to view vital signs summary information or customized patient reports. Thus, technological advancement in smart medical devices could propel the growth of the smart medical device market in the future.

Report Segmentation and Scope



Product Type-Based Insights



Based on product type, the smart medical device market is bifurcated into diagnostic devices, therapeutic devices, injury prevention & rehabilitation devices, and others. The diagnostic devices segment held a larger market share in 2022. Smart devices help improve well-being and stay healthy by making them reliable, convenient, personalized, and secure. Therefore, intelligent sensors, microcontrollers, actuators, connectivity modules, and others, together with software, have IoT possess a great potential to prevent diseases and improve health. Additionally, next-generation sleep monitors with "XENSIV" radar sensors are examples of improved sleep quality. People suffering from sleep apnea experience developing lifestyle disorders such as obesity, depression, and type 2 diabetes. However, radar solutions such as "Sleepiz" or "Tsingray" act as a critical factor that enables the digitalization of medical healthcare to improve the sleeping patterns of the population suffering from sleep apnea. The rising number of diagnostics devices intended for detecting chronic diseases results in high demand, thereby catalyzing the market for the diagnostic device segment for the forecast period 2022-2030.

Test Type-Based Insights



Based on test type, the global smart medical device market is segmented as portable, wearable, and others. The wearable segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022-2030. Wearable smart medical devices, including smartphones and tablets, are utilized with software applications to support healthcare services. Also, wearable technology serves the healthcare business in several ways. Fitness smart devices, remote patient monitoring devices, and wearable medical gadgets are a few examples of smart medical devices.

Moreover, utilizing wearable medical devices enhances the treatment of chronic illnesses by monitoring vital risk factors such as blood pressure, glucose, and others. For example, an insulin pump is a wearable medical device used to provide insulin in the management of diabetes. This smart wearable medical device delivers consistent doses of continuous infusion insulin among patients who have diabetes. Further, compared to daily injections, a wearable medical device is anticipated to produce long-term cost savings as well as effective and quick readings to lower glucose levels. The factors mentioned above are responsible for influential segmental growth for the forecast period of 2020-2030.

End User-Based Insights



Based on end users, the global smart medical device market is segmented as hospitals & clinics, homecare settings, and others. The hospitals & clinics segment will account for the largest share of the smart medical devices market. There is a high adoption of innovative medical devices in hospitals & clinics. Technological advancements in smart devices assist clinicians or physicians in detecting patient abnormalities. Paramedic patient monitoring is one such example where the ambulance is delivering a patient to the hospital, where wireless patient monitoring solutions will allow doctors in the hospitals to track a patient's condition in real-time and plan the patient care (including emergency surgeries well in advance). Such notable developments in intelligent medical devices will enhance adoption in hospitals, thereby dominating market growth for the forecast period 2020-2030.

Regional Analysis



The North American smart medical device market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the rising chronic diseases-a standalone factor positively influencing the growth of the market. Additionally, technological advancements in monitoring devices further enhance the overall market growth. Moreover, companies launching innovative products by the US manufacturers further enhance the smart medical devices adoption in the US, thereby dominating the market growth for the forecast period 2020-2030. For instance, in September 2023, B. Braun Medical Inc. announced the receipt of FDA approval for "AQUAbase nX Reverse Osmosis System". The AQUAbase nX is a single-stage reverse osmosis device offering high-quality water intended for dialysis patients without the utility of chemicals. Therefore, the product has upto a 75% raw water conversion rate that may conserve water usage, reducing the cost of power, pre-treatment, and maintenance of equipment.

Further, companies are developing innovative products through collaboration. For example, in March 2023, Medtronic announced a collaboration with NVIDIA to build an Artificial Intelligence (AI) platform for medical devices. The collaboration enhanced the integration of NVIDIA healthcare and edge AI technologies into Medtronic's "Medtronic’s GI Genius intelligent endoscopy module. Genius is the first FDA-approved AI-assisted colonoscopy tool that will help physicians detect polyps that can lead to colorectal cancer. Such notable developments will accelerate the adoption of smart medical devices in the US for the forecast period 2020-2030.

Likewise, Asia Pacific will account for the highest CAGR for the smart medical devices market for the forecast period 2020-2030.

The report profiles leading players operating in the global smart medical device market. These include Abbott Laboratories, Apple, Inc., Dexcom, Inc., Fitbit, Inc., F. Hoffman-La-Roche Ltd., Johnson & Johnson, Medtronic, Zephyr, and Sonova.

In March 2020, Fitbit LLC announced a partnership with FibriCheck, an innovative health screening and monitoring app company to enable users in France, Germany, Italy, and Spain to monitor patient's heart rhythm for irregularities such as atrial fibrillation (AFib) directly from Fitbit LLC smartwatch. This strategy will help to expand Fitbit LLC's business across Europe, thereby strengthening its market position in Europe.

In April 2020, Dexcom announced that amid the COVID-19 pandemic, it announced a new product launch of the "Dexcom G6 CGM System". This new product launch is capable of remote patient monitoring in the hospital setting. Such a development strategy is likely to expand product offerings in various healthcare sectors, thereby strengthening Dexcom's market presence worldwide.

Company Profiles

  • Abbott Laboratories
  • Apple, Inc.
  • Dexcom, Inc.
  • Fitbit, Inc.
  • F. Hoffman-La-Roche Ltd.
  • Johnson & Johnson
  • Medtronic
  • NeuroMetrix, Inc.
  • Zephyr
  • Sonova

Smart Medical Devices Market Report Scope

Report Attribute Details
Market size in 2023 US$ 40.26 Billion
Market Size by 2031 US$ 129.30 Billion
Global CAGR (2023 - 2031) 15.70%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product Type
  • Diagnostic Devices
  • Therapeutic Devices
  • Injury Prevention & Rehabilitation Devices
  • Others
By Test Type
  • Portable and Wearable
By End User
  • Hospitals & Clinics
  • Homecare Settings
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott Laboratories
  • Apple, Inc.
  • Dexcom, Inc.
  • Fitbit, Inc.
  • F. Hoffman-La-Roche Ltd.
  • Johnson & Johnson
  • Medtronic
  • NeuroMetrix, Inc.
  • Zephyr
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    • Abbott Laboratories
    • Apple, Inc.
    • Dexcom, Inc.
    • Fitbit, Inc.
    • F. Hoffman-La-Roche Ltd.
    • Johnson & Johnson
    • Medtronic
    • NeuroMetrix, Inc.
    • Zephyr
    • Sonova

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • 3.1 Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • 3.2 Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • 3.3 Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • 3.4 Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Smart Medical Devices Market


    -->